Save your place

Sign in to WhoBought

Please try again later.

Jim Simons's Recursion Pharmaceuticals, Inc. (RXRX) position

Yes: as of Q1 2026, Jim Simons holds 2.4M shares of RXRX worth $7.4M (0.0% of the disclosed portfolio). Last quarter the position was opened. First disclosed Q1 2022.
View full portfolio →
Current value
$7.4M
Shares held
2.4M
% of portfolio
0.0%
Est. average buy price (i)
$3.86
Quarter-end price
$3.07

Estimated trade prices

Average price in quarters with purchases
$4.98
Average prices in quarters with sales
  • Q2 2023: $7.00 (66K shares sold)
  • Q3 2022: $10.13 (246K shares sold)

RXRX price vs Simons's position

1Y 3Y 5Y MAX
Dates
$2$20$4020222023202420252026New position of 178K shares · Q1 2022. Average closing price $10.63 · Price range $6.16–$18.03178KsharespurchasedAdded 83K shares (46.6%) · Q2 2022. Average closing price $6.69 · Price range $5.04–$9.2683KsharespurchasedSold 246K shares (94.2%) · Q3 2022. Average closing price $10.13 · Price range $7.83–$13.60246KsharessoldAdded 179K shares (over 1,000%) · Q4 2022. Average closing price $9.81 · Price range $7.16–$12.70179KsharespurchasedAdded 222K shares (114.3%) · Q1 2023. Average closing price $7.93 · Price range $6.42–$9.64222KsharespurchasedSold 66K shares (15.8%) · Q2 2023. Average closing price $7.00 · Price range $4.56–$9.9466KsharessoldNew position of 2.4M shares · Q1 2026. Average closing price $3.86 · Price range $2.84–$4.962.4Msharespurchased
Average closing price · filing quarter
$3.86
Price range · filing quarter
$2.84 – $4.96
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 New +2.4M +$9.3M – 2.4M May 14, 2026
Q2 2023 Reduced −66K −$459K −15.8% 350K Aug 11, 2023
Q1 2023 Added +222K +$1.8M +114.3% 416K May 12, 2023
Q4 2022 Added +179K +$1.8M +1,175.7% 194K Feb 13, 2023
Q3 2022 Reduced −246K −$2.5M −94.2% 15K Nov 14, 2022
Q2 2022 Added +83K +$557K +46.6% 262K Aug 12, 2022
Q1 2022 New +178K +$1.9M – 178K May 13, 2022
Data through Q1 2026 · filed May 14, 2026
7 grouped rows from 7 quarters

More Simons positions

United Therapeutics Corporation(UTHR)
$1.1B
1.7% of portfolio

Palantir Technologies Inc.(PLTR)
$997M
1.6% of portfolio

Apple Inc.(AAPL)
$778M
1.2% of portfolio

Kinross Gold Corporation(KGC)
$780M
1.2% of portfolio

Micron Technology, Inc.(MU)
$731M
1.1% of portfolio

VeriSign, Inc.(VRSN)
$700M
1.1% of portfolio

Common questions

Does Jim Simons own RXRX?

Yes. As of Q1 2026, Jim Simons disclosed 2.4M shares of RXRX, worth $7.4M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jim Simons buy RXRX?

Jim Simons first disclosed a RXRX position in Q1 2022; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jim Simons sell RXRX?

The quarter-by-quarter table above shows each sale and reduction Jim Simons disclosed in RXRX. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of RXRX does Jim Simons own?

Jim Simons disclosed 2.4M shares of RXRX as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jim Simons pay for RXRX?

Jim Simons's estimated average buy price for RXRX is $3.86, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.